Effect of Levothyroxine on the Some Biological Variables in Women with Hypothyroidism
Downloads
A recently discovered lipolytic adipokine called zinc-α2-glycoprotein (ZAG) has been linked to the control of lipid and glucose metabolism in a variety of metabolic diseases. The present study aimed to evaluated level of ZAG, malondialdehyde MDA, iron, lipid profile, thyroid stimulating hormones TSH, thyroxine T4, and triiodothyronine T3 in hypothyroidism patients after and before treatment. The cross sectional study investigated 90 women (60 patients newly diagnosed with hypothyroidism and 30 controls), their ages between (16- >60) years. All women with hypothyroidism diagnosed before and after treatment with levothyroxine for 3 months. The patients were referred to private clinics in Samarra from September 2024 to December 2025. This study showed decrease ZAG and iron level in hypothyroidism women before treatment, while increase after treatment as compared with control, ZAG value were (98.68±8.30, 110.96±7.55, 159.06±19.11) μg/ml respectively and iron value were (84.74± 8.04, 109.63± 13.95, 159.06±19.11) g/dL, at p-value P<0.001. MDA levels were significantly higher pre-treatment and elevated post-treatment compared to the control group(5.46±0.60, 2.59±0.44, 1.83±0.76) nmol\ml respectively, p-value <0.001. The lipid profile comprises total cholesterol, triglycerides, low-density lipoprotein (LDL), and high-density lipoprotein (HDL). A statistically significant difference (P-Value = 0.01) was noted, Value of Cholesterol were (223.10± 11.72, 203.77± 9.09, 175.53± 9.44) mg/dl, while (132.03±36.58, 121.05± 4.25, 106.40± 8.93) mg/dl in triacylglycerol, (152.87±13.79, 128.57±10.41, 106.84±10.46 ) mg/dl in LDL, (35.51±1.90, 50.55±3.32, 47.93±2.80 )mg/dl in HDL. Serum ZAG , iron, HDL, T3, and T4, decreased before treatment while treatment with levothyroxine for period 3 months improve level of these parameters. Furthermore increase TSH , MDA, total cholesterol, triacylglycerol, LDL, levels in hypothyroidism patients and with treatment decrease it.
1. Chaker L, Razvi S, Bensenor IM, Azizi F, Pearce EN, Peeters RP. Hypothyroidism (primer). Nature Reviews: Disease Primers. 2022;8(1).
2. Wilson SA, Stem LA, Bruehlman RD. Hypothyroidism: Diagnosis and treatment. American family physician. 2021;103(10):605-13.
3. Bode H, Ivens B, Bschor T, Schwarzer G, Henssler J, Baethge C. Association of hypothyroidism and clinical depression: a systematic review and meta-analysis. JAMA psychiatry. 2021;78(12):1375-83.
4. Severo JS, Morais JBS, Beserra JB, Dos Santos LR, de Sousa Melo SR, de Sousa GS, et al. Role of zinc in zinc-α2-glycoprotein metabolism in obesity: a review of literature. Biological trace element research. 2020;193:81-8.
5. Liu M, Zhu H, Dai Y, Pan H, Li N, Wang L, et al. Zinc-α2-glycoprotein is associated with obesity in Chinese people and HFD-induced obese mice. Frontiers in physiology. 2018;9:62.
6. Xiao X-H, Qi X-Y, Li J-Y, Wang Y-B, Wang Y-D, Liao Z-Z, et al. Serum zinc-α2- glycoprotein levels are elevated and correlated with thyroid hormone in newly diagnosed hyperthyroidism. BMC Endocrine Disorders. 2019;19:1-6.
7. Banaszak M, Górna I, Przysławski J. Zinc and the innovative zinc-α2-glycoprotein adipokine play an important role in lipid metabolism: a critical review. Nutrients. 2021;13(6):2023.
8. Xiao X-H, Wang Y-D, Qi X-Y, Wang Y-Y, Li J-Y, Li H, et al. Zinc alpha2 glycoprotein protects against obesity-induced hepatic steatosis. International journal of obesity. 2018;42(8):1418-30.
9. Chakrabarti SK, Ghosh S, Banerjee S, Mukherjee S, Chowdhury S. Oxidative stress in hypothyroid patients and the role of antioxidant supplementation. Indian journal of endocrinology and metabolism. 2016;20(5):674-8.
10. Guerrero A, Pamplona R, Portero-Otín M, Barja G, López-Torres M. Effect of thyroid status on lipid composition and peroxidation in the mouse liver. Free Radical Biology and Medicine. 1999;26(1-2):73-80.
11. Franzese A, Salerno M, Argenziano A, Buongiovanni C, Limauro R, Tenore A. Anemia in infants with congenital hypothyroidism diagnosed by neonatal screening. Journal of endocrinological investigation. 1996;19:613-9.
12. Lippi G, Montagnana M, Salvagno GL, Guidi GC. Should women with abnormal serum thyroid stimulating hormone undergo screening for anemia? Archives of pathology & laboratory medicine. 2008;132(3):321-2.
13. Leedman PJ, Stein AR, Chin WW, Rogers JT. Thyroid Hormone Modulates the Interaction between Iron Regulatory Proteins and the Ferritin mRNA Iron-responsive Element (∗). Journal of biological chemistry. 1996;271(20):12017-23.
14. Levenson CW, Fitch CA. Effect of altered thyroid hormone status on rat brain ferritin H and ferritin L mRNA during postnatal development. Developmental Brain Research. 2000;119(1):105-9.
15. Th B, Charlton R, Cook J, Finch C. Iron metabolism in man. Oxford: Blackwell Scientific; 1979.
16. Dallman PR, Beutler E, Finch C. Effects of iron deficiency exclusive of anaemia. 1978.
17. Zeng G, Mai Z, Xia S, Wang Z, Zhang K, Wang L, et al. Prevalence of kidney stones in
18. China: an ultrasonography based cross‐sectional study. BJU international. 2017;120(1):109-16.
19. Hennessy DJ, Reid GR, Smith FE, Thompson SL. Ferene—a new spectrophotometric reagent for iron. Canadian journal of chemistry. 1984;62(4):721-4.
20. Omari A. Relation between Serum Homocysteine Level and Lipid Profile in Patients with Dyslipidemia. Education. 2002;2004.
21. Hassan NA, Abbas SK. Evaluation Serum levels of Leptin, CRP and Lipid profile in Hypothyroid Women in Kirkuk city/Iraq. Journal of Pharmaceutical Negative Results. 2022:2239-46.
22. Verma A, Jayaraman M, Kumar H, Modi KD. Hypothyroidism and obesity. Saudi Med J. 2008;29(8):1135-8.
23. Siddharth L, Blessing LT, Wood KL, Luo J. Engineering knowledge graph from patent database. Journal of Computing and Information Science in Engineering. 2022;22(2):021008.
24. Wolf M, Weigert A, Kreymann G. Body composition and energy expenditure in thyroidectomized patients during short-term hypothyroidism and thyrotropin-suppressive thyroxine therapy. European Journal of Endocrinology. 1996;134(2):168-73.
25. Seppel T, Kosel A, Schlaghecke R. Bioelectrical impedance assessment of body composition in thyroid disease. European journal of endocrinology. 1997;136(5):493-8.
26. Prajitno JH, Soelistijo SA, Susanto H, Pranoto A. Thyroid Dysfunction Associated with Lipid Profile Changes (Thyroid Dysfunction in Lipid Profile Changes). International Journal of Pharmaceutical Research (09752366). 2020;12(3).
27. Khorsheed HO, Sarhat ER. Impact of Medical Therapy on the Zinc-Α2-Glycoprotein and Ischemia Modified Albumin Levels in Patients with Hypothyroidism. Bahrain Medical Bulletin. 2024;46(2).
28. Abd KA, AL-Qaisi AHJ, Hussein SA. Role of Zinc Alpha2-Glycoprotein and Retinol-Binding Protein-4 in Iraqi Women with Thyroid Dysfunctions. Iraqi Journal of Science. 2024:5385-94.
29. Simó R, Hernández C, Sáez-López C, Soldevila B, Puig-Domingo M, Selva DM. Thyroid hormone upregulates zinc-α2-glycoprotein production in the liver but not in adipose tissue. PLoS One. 2014;9(1):e85753.
30. Sinha RA, Singh BK, Yen PM. Direct effects of thyroid hormones on hepatic lipid metabolism. Nature Reviews Endocrinology. 2018;14(5):259-69.
31. Tian M, Liang Z, Liu R, Li K, Tan X, Luo Y, et al. Effects of sitagliptin on circulating zinc- α2-glycoprotein levels in newly diagnosed type 2 diabetes patients: a randomized trial. European journal of endocrinology. 2016;174(2):147-55.
32. Lei L, Li K, Li L, Fang X, Zhou T, Zhang C, et al. Circulating zinc-α2-glycoprotein levels are low in newly diagnosed patients with metabolic syndrome and correlate with adiponectin. Nutrition & metabolism. 2017;14:1-7.
33. Baskol G, Atmaca H, Tanrıverdi F, Baskol M, Kocer D, Bayram F. Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment. Experimental and Clinical Endocrinology & Diabetes. 2007;115(08):522-6.
34. Halliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. The American journal of clinical nutrition. 1993;57(5):715S-25S.
35. Halliwell B. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. The American journal of medicine. 1991;91(3):S14-S22.
36. Rostaei Rad N, Vakili M, Zavar-reza J, Rezaie S, Shirvani AR. The relationship between thyroid hormone levels and body iron status in iranian hypothyroidism patients. International Journal of Medical Laboratory. 2016;3(3):176-84.
37. Jung CH, Sung KC, Shin HS, Rhee EJ, Lee WY, Kim BS, et al. Thyroid dysfunction and their relation to cardiovascular risk factors such as lipid profile, hsCRP, and waist hip ratio in Korea. The Korean journal of internal medicine. 2003;18(3):146.
38. Scarabottolo L, Trezzi E, Roma P, Catapano AL. Experimental hypothyroidism modulates the expression of the low density lipoprotein receptor by the liver. Atherosclerosis. 1986;59(3):329-33.
39. Jiskra J, Limanova Z, Antosova M. Thyroid diseases, dyslipidemia and cardiovascular risk. Vnitrni lekarstvi. 2007;53(4):382-5.
40. Tulloch B, Lewis B, Fraser TR. Triglyceride metabolism in thyroid disease. The Lancet. 1973;301(7800):391-4.
41. Duntas LH. Thyroid disease and lipids. Thyroid. 2002;12(4):287-93.
42. Rustam SS, Hassan BF. Assessment of inflammatory marker (Hs-CRP and OPN) and other parameters in Hypothyroidism. Assessment. 2021;44(06).
43. Zahra N, Ali A, Kousar S, Malik A, Zaheer A, Malik IR. Study on significant changes in calcium, phosphorus and thyroid hormones level in hypothyroidism patients. Advancements in Life Sciences. 2020;8(1):85-8.
44. Mohamed RJ. Relationship Between Disorder of Thyroid Gland and the levels of T3, T4 and TSH Hormones. journal of kerbala university. 2016;14(2).
45. Payne D. BIOCHEMICAL AND PHYSIOLOGICAL ASPECTS OF HUMAN NUTRITION.
46. Journal of the American Dietetic Association. 2001;101(5):598-.
47. Choksi NY, Jahnke GD, St. Hilaire C, Shelby M. Role of thyroid hormones in human and laboratory animal reproductive health. Birth defects research part B: Developmental and reproductive toxicology. 2003;68(6):479-91.
48. Sawant SU, Chandran S, Almeida AF, Rajan M. Correlation between oxidative stress and thyroid function in patients with nephrotic syndrome. International journal of nephrology. 2011;2011(1):256420.
49. Fontenelle L, Feitosa M, Severo J, Freitas T, Morais J, Torres-Leal F, et al. Thyroid function in human obesity: underlying mechanisms. Hormone and Metabolic Research. 2016;48(12):787-94.
